Brief: Shanghai Henlius Biotech Says License Agreement With Dr. Reddy's For HLX15
06/02/2025 10:38
Feb 6 (Reuters) - Shanghai Henlius Biotech Inc
2696.HK :
* LICENSE AGREEMENT WITH DR. REDDY'S FOR HLX15
* DR. REDDY'S SHALL PAY COMPANY US$33 MLN
* GRANTED DR. REDDY'S A LICENSE TO DEVELOP, MANUFACTURE AND
COMMERCIALIZE HLX15
Source text: ID:nHKS92VVM6
Further company coverage: 2696.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shanghai Henlius Biotech
See all newsBrief: Shanghai Henlius Biotech Says Wenjie Zhang Resigns As Chairman
Brief: Shanghai Henlius Biotech Enters Collaboration And License Agreement With Amberstone Biosciences
Brief: Shanghai Henlius Biotech Says NDA For 120 Mg Biosimilar Denosumab HLX14 Accepted By NMPA
China's Henlius H1 revenue jumps on drug sales, license income
Brief: Shanghai Henlius Biotech Logs HY Profit RMB 430.4 Mln